RSS-Feed abonnieren
DOI: 10.1055/s-0028-1087675
Development of a New Chiral Spiro Oxazolinylpyridine Ligand (Spymox) for Asymmetric Catalysis
Publikationsverlauf
Publikationsdatum:
15. Januar 2009 (online)
![](https://www.thieme-connect.de/media/synlett/200902/lookinside/thumbnails/10.1055-s-0028-1087675-1.jpg)
Abstract
A novel optically active 2-(oxazolinyl)pyridine ligand (Spymox) having a spiro binaphthyl backbone was synthesized from an α,α-disubstituted α-amino acid (H-Bin-OH), and successfully used in palladium-catalyzed asymmetric allylic alkylations to afford the corresponding alkylated products with 99% ee.
Key words
ligand design - α-amino acid - spiro compounds - asymmetric catalysis - allylic substitution
- 1 A recent review for chiral phosphine
ligands on a spiro scaffold:
Xie J.-H.Zhou Q.-L. Acc. Chem. Res. 2008, 41: 581 - Most of the reported efficient spiro chiral ligands have a 1,1′-spirobiindane backbone. For examples, see:
-
2a
Birman VB.Rheingold AL.Lam K.-C. Tetrahedron: Asymmetry 1999, 10: 125 -
2b
Hu A.-G.Fu Y.Xie J.-H.Zhou H.Wang L.-X.Zhou Q.-L. Angew. Chem. Int. Ed. 2002, 41: 2348 -
2c
Xie J.-H.Wang L.-X.Fu Y.Zhu S.-F.Fan B.-M.Duan H.-F.Zhou Q.-L. J. Am. Chem. Soc. 2003, 125: 4404 -
2d
Xie J.-H.Duan H.-F.Fan B.-M.Cheng X.Wang L.-X.Zhou Q.-L. Adv. Synth. Catal. 2004, 346: 625 -
2e
Zhu S.-F.Yang Y.Wang L.-X.Liu B.Zhou Q.-L. Org. Lett. 2005, 7: 2333 -
2f
Cheng X.Zhang Q.Xie J.-H.Wang L.-X.Zhou Q.-L. Angew. Chem. Int. Ed. 2005, 44: 1118 -
2g
Zhu S.-F.Xie J.-B.Zhang Y.-Z.Li S.Zhou Q.-L. J. Am. Chem. Soc. 2006, 128: 12886 -
2h
Chen C.Zhu S.-F.Liu B.Wang L.-X.Zhou Q.-L. J. Am. Chem. Soc. 2007, 129: 12616 - Examples of spiro chiral ligands other than those listed in ref. 2:
-
3a
Jiang Y.Mi A.Yan M.Sun J.Lou R.Deng J. J. Am. Chem. Soc. 1997, 119: 9570 -
3b
Arai MA.Arai T.Sasai H. Org. Lett. 1999, 1: 1795 -
3c
Arai MA.Kuraishi M.Arai T.Sasai H. J. Am. Chem. Soc. 2001, 123: 2907 -
3d
Wu S.-L.Zhang W.-C.Zhang Z.-G.Zhang X.-M. Org. Lett. 2004, 6: 3565 -
3e
Lin CW.Lin C.-C.Lam LF.-L.Au-Yeung TT.-L.Chan ASC. Tetrahedron Lett. 2004, 45: 7379 -
3f
Lait SM.Parvez M.Keay BA. Tetrahedron: Asymmetry 2004, 15: 155 -
3g
Guo Z.Guan X.Chen Z. Tetrahedron: Asymmetry 2006, 17: 468 -
3h
Koranne PS.Tsujihara T.Arai MA.Bajracharya GB.Suzuki T.Onitsuka K.Sasai H. Tetrahedron: Asymmetry 2007, 18: 919 - Recent reviews on nitrogen-containing chiral ligands:
-
4a
Fache F.Schulz E.Tommasino ML.Lemaire M. Chem. Rev. 2000, 100: 2159 -
4b
McManus HA.Guiry PJ. Chem. Rev. 2004, 104: 4151 - Synthesis of H-Bin-OR and their application to peptide chemistry:
-
5a
Mazaleyrat J.-P.Gaucher A.Wakselman M.Tchertanov L.Guilhem J. Tetrahedron Lett. 1996, 37: 2971 -
5b
Mazaleyrat J.-P.avrda J.Wakselman M. Tetrahedron: Asymmetry 1997, 8: 619 -
5c
Mazaleyrat J.-P.Boutboul A.Lebars Y.Gaucher A.Wakselman M. Tetrahedron: Asymmetry 1998, 9: 2701 -
5d
Mazaleyrat J.-P.Wright K.Gaucher A.Wakselman M.Oancea S.Formaggio F.Toniolo C.Setnika V.Kapitán J.Keiderling TA. Tetrahedron: Asymmetry 2003, 14: 1879 -
6a
Catalytic Asymmetric Synthesis
2nd
ed.:
Ojima I. Wiley-VCH; New York: 2000. -
6b
Comprehensive Asymmetric
Catalysis
Vol. 1-3:
Jacobsen EN.Pfaltz A.Yamamoto H. Springer; New York: 1999. -
7a
Dalko PI.Moisan L. Angew. Chem. Int. Ed. 2004, 43: 5138 -
7b
Berkessel A.Gröger H. Asymmetric Organocatalysis Wiley-VCH; Weinheim: 2005. -
7c
Enantioselective
Organocatalysis: Reactions and Experimental Procedures
Dalko PI. Wiley-VCH; Weinheim: 2007. - Reviews on the asymmetric allylic alkylation reaction:
-
8a
Paquin J.-F.Lautens M. In Comprehensive Asymmetric Catalysis Suppl. 2:Jacobsen EN.Pfaltz A.Yamamoto H. Springer; Berlin: 2004. p.73-95 ; and references therein -
8b
Pfaltz A.Lautens M. In Comprehensive Asymmetric Catalysis Vol. 2:Jacobsen EN.Pfaltz A.Yamamoto H. Springer; New York: 1999. p.833-884 ; and references therein - Palladium-catalyzed asymmetric allylic alkylations with fluorinated carbanion:
-
11a
Fukuzumi T.Shibata N.Sugiura M.Yasui H.Nakamura S.Toru T. Angew. Chem. Int. Ed. 2006, 45: 4973 -
11b
Jiang B.Huang Z.-G.Cheng K.-J. Tetrahedron: Asymmetry 2006, 17: 942 -
11c
Zhang F.Song ZJ.Tschaen D.Volante RP. Org. Lett. 2004, 6: 3775 -
11d
Komatsu Y.Sakamoto T.Kitazume T. J. Org. Chem. 1999, 64: 8369 - 12 For compounds 6a, 8c, see:
Imamoto T.Nishimura M.Koide A.Yoshida K. J. Org. Chem. 2007, 72: 7413 - 13 For compounds 6b-d, 8b, see:
Kinoshita N.Kawabata T.Tsubaki K.Bando M.Fuji K. Tetrahedron 2006, 62: 1756 - 14 For compound 8a,
see:
Braga AL.Vargas F.Sehnem JA.Braga RC. J. Org. Chem. 2005, 70: 9021 - 15 For compound 8d,
see:
Jiang B.Huang Z.-G.Cheng K.-J. Tetrahedron: Asymmetry 2006, 17: 942
References and Notes
Palladium-catalyzed asymmetric allylic alkylation using a spiro chiral ligand having a 1,1′-spirobiindane backbone (SDP) has been reported, see ref. [²d] .
10A previous report on asymmetric allylic alkylation using pymox-Pd complex also shows moderate enantioselectivity (50% ee): Nordström K., Macedo E., Moberg C.; J. Org. Chem.; 1997, 62: 1604
16Compound 1: ¹H NMR (300 MHz, CDCl3): δ = 8.71 (m, 1 H), 8.08 (m, 1 H), 7.95 (m, 4 H), 7.77 (m, 1 H), 7.65 (d, J = 8.0 Hz, 1 H), 7.50 (d, J = 8.4 Hz, 1 H), 7.46-7.38 (m, 4 H), 7.33 (d, J = 8.8 Hz, 1 H), 7.27-7.20 (m, 2 H), 4.65 (d, J = 8.8 Hz, 1 H), 3.95 (d, J = 8.8 Hz, 1 H), 2.94 (d, J = 13.1 Hz, 1 H), 2.88 (d, J = 13.3 Hz, 1 H), 2.72 (d, J = 13.3 Hz, 1 H), 2.65 (d, J = 13.1 Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 162.1, 149.8, 147.0, 136.7, 135.4, 134.7, 134.5, 133.7, 133.1, 133.0, 132.1, 131.9, 128.7, 128.5, 128.4, 128.4, 128.3, 127.5, 127.4, 127.2, 126.0, 125.7, 125.4, 125.1, 124.4, 82.5, 77.3, 44.4, 43.5. IR (neat): 3847, 3741, 3475, 3053, 2938, 1635, 1577, 1469, 1361, 1302, 1092, 968, 813, 751, 696, 615 cm-¹. Anal. Calcd (%) for C30H22N2O: C, 84.48; H, 5.20; N, 6.57. Found: C, 84.67; H, 5.15; N, 6.36. [α]D -72.4 (c 1.25, CHCl3).
17Compound 4: ¹H NMR (300 MHz, CDCl3): δ = 8.45 (m, 1 H), 8.23 (m, 2 H), 7.96-7.86 (m, 5 H), 7.55 (m, 1 H), 7.48-7.37 (m, 6 H), 7.29-7.23 (m, 2 H), 5.19 (dd, J = 5.2, 8.0 Hz, 1 H), 4.01 (dd, J = 8.0, 11.5 Hz, 1 H), 3.83 (dd, J = 5.2, 11.5 Hz, 1 H), 3.23 (d, J = 13.7 Hz, 1 H), 3.11 (d, J = 12.4 Hz, 1 H), 2.54 (d, J = 13.7 Hz, 1 H), 2.45 (d, J = 12.4 Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.0, 149.6, 148.2, 137.8, 135.4, 135.4, 134.8, 134.6, 134.4, 133.2, 133.2, 133.1, 132.0, 132.0, 128.6, 128.4, 128.4, 128.1, 128.1, 127.4, 126.6, 126.1, 126.0, 125.6, 125.4, 122.3, 70.2, 66.9, 41.0, 38.9. IR (neat): 3846, 3343, 3053, 2928, 1667, 1525, 1457, 1324, 1245, 1058, 817, 752, 697, 621, 436 cm-¹. Anal. Calcd (%) for C30H24N2O2: C, 80.06; H, 5.44; N, 6.30. Found: C, 81.34; H, 5.74; N, 6.03. [α]D -90.5 (c 1.0, CHCl3).
18Compound 5e: ¹H NMR (300 MHz, CDCl3): δ = 7.29-7.05 (m, 8 H), 6.60 (d, J = 15.3 Hz, 1 H), 6.41-6.28 (m, 2 H), 2.36 (s, 3 H), 2.32 (s, 3 H), 2.13 (s, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 170.2, 139.3, 138.4, 138.2, 136.2, 132.6, 129.0, 128.9, 128.63, 128.57, 127.8, 127.5, 124.2, 124.0, 76.4, 21.6, 21.49, 21.45. Anal. Calcd (%) for C19H20O2: C, 81.40; H, 7.19; O, 11.41. Found: C, 81.06; H, 6.62.
19Compound 6e: ¹H NMR (300 MHz, CDCl3): δ = 7.26-7.00 (m, 8 H), 6.44 (d, J = 15.6 Hz, 1 H), 6.29 (dd, J = 15.6 Hz, 1 H), 4.21 (dd, J = 10.8, 8.4 Hz, 1 H), 3.94 (d, J = 10.8 Hz, 1 H), 3.70 (s, 3 H), 3.53 (s, 3 H), 2.33 (s, 3 H), 2.31 (s, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 168.4, 168.0, 140.3, 138.4, 138.1, 136.9, 131.9, 129.1, 128.7, 128.5, 128.0, 127.2, 124.8, 123.7, 57.7, 52.76, 52.74, 52.60, 52.57, 49.3. Anal. Calcd (%) for C22H24O4: C, 74.98; H, 6.86; O, 18.16. Found: C, 74.69; H, 6.86. [α]D +24.1 (c 0.63, CHCl3). The er was determined by HPLC [hexane-2-PrOH (96:4), 0.5 mL/min] using a CHIRALPAK AD column (0.46 cm × 25 cm): t R (major isomer) = 23.0 min; t R (minor isomer) = 26.5 min.